LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA – Neurocrine Biosciences, Inc. Transaction History
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA portfolio value:
$21.14M
portfolio value
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.37% | -15.83K shares | 195K | $106.21 | 199.09K |
| Q2 2022 | share | Increase | +12.78% | 24.36K shares | 3.08M | $97.48 | 214.93K |
| Q1 2022 | share | Decrease | -27.45% | -72.09K shares | -4.50M | $93.75 | 190.56K |
| Q4 2021 | share | Increase | +9.45% | 22.68K shares | -634K | $84.63 | 262.66K |
| Q3 2021 | share | Increase | +10.70% | 23.19K shares | 1.90M | $95.91 | 239.98K |
| Q2 2021 | share | Increase | +44.66% | 66.92K shares | 6.52M | $97.32 | 216.79K |
| Q1 2021 | share | Increase | 0.00% | 149.86K shares | 14.57M | $97.25 | 149.86K |